Market Chat and Introduction to Six Figure Slide Trading
Wednesday, June 21, 2023 4:30 pm ET / 1:30 pm PT
Listen in as Option Hotline Chief Options Strategist, Keith Harwood, talks today's markets with guest panelist Jake Davis at this live market chat webinar. Jake will introduce us to the Six Figure Slide trading program and Keith will compare with his Option Trend Trader program.
Listen in and get your questions answered live by Keith and Jake! Save your seat today as all attendees will receive a free giveaway!
Artificial intelligence (AI) stocks are exploding, as hoped.
For one, according to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030.
Two, according to Marketing AI Institute, “Artificial intelligence will, on average, boost rates of profitability by 38% and provide an economic boost of $14 trillion in additional gross value by 2035, according to research by Accenture.
Three, investors can’t get enough of the ChatGPT craze. In fact, according to Economist,” Since ChatGPT was launched in November, a new mini-industry has mushroomed that has defied the broader slump in tech. Not a week goes by without someone unveiling a “generative” artificial intelligence (AI) underpinned by “foundation” models – the large and complex algorithms that give ChatGPT and other AIs like it their intelligence.
Four, the U.S. Chamber of Commerce just said, “virtually every business and government agency" will use AI, noting that it will have a "profound" impact on society, the economy, and national security,” as quoted by Seeking Alpha.
So, it comes as no surprise that some of the AI stocks we’ve spoken about are moving.
Nvidia (NVDA)
Nvidia is a no-brainer in the AI space.
AI has been a strong catalyst for NVDA, too. CEO Jensen Huang told analysts that activity around Nvidia’s AI infrastructure “has gone through the roof” since the public debut of Open AI’s ChatGPT, as noted by MarketWatch.com.
For many years, I have observed a similar trading pattern for most newly issued stocks. I have been particularly sensitive to the trading activity of these new issues because I was in charge of trading these stocks when I first entered the investment business over 23 years ago. Although nothing in the investment business is for certain, and most techniques, following a period during which they work exceptionally well, undergo a period of erosion and disinterest, this method seems to have successfully withstood the rigors of various market environments and of time. Whether the climate for public offerings is hot or cold, this technique on balance seems to work, although of course, the degree of success seems to be influenced somewhat by the overall market.
Typically, once a new issue begins to trade, I look for the following characteristics regardless of the price at which the public offering is completed. Often, price will either advance or at least move sideways for a few days. The reason for this price movement is that the selling syndicate that initially offered the shares to the public for sale supports the price of the stock for a period of time. If the original offering is priced conservatively, the syndicate’s price support activity is not as critical. However, if the underwriter attempts to raise the maximum amount for the selling company, it may stretch the market to the point where prospective buyers believe it to be too expensive; price then declines. In any case, the syndicate usually is able to muster enough buying to support the offering price.
The first profit opportunity we will review is in CABA, or Cabaletta Bio Inc. CABA is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases.
The monthly chart shows that CABA has been above the moving average line since October. After a fivemonth pause, an upside breakout appears to be imminent.
The daily chart shows that CABA rocketed from below 1 in October to almost 13 in February. The next targets are 15 and 18.
We recommend buying CABA stock at the current price level.
PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.
1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis.
2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.
3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.
4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.
5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.
6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.
7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.
8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.
If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription TradeWins Publishing, 528 North Country Rd., St. James, NY 11780
没有评论:
发表评论